Identification of Biomarkers for Obstructive Sleep Apnoea Syndrome
NCT ID: NCT02043483
Last Updated: 2015-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2012-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project aims to determine non-invasive biomarkers that may allow better comprehension of the metabolic consequences of OSAS, as well as assess the effect of Continuous positive airway pressure (CPAP) on these metabolic parameters.
This project will integrate the clinical, metabolic, genetic/proteomic and biologic systems to further explore the mechanisms behind OSAS, as well as the effect of the treatment with CPAP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment
NCT01976052
Biomarkers in Obstructive Sleep Apnea Surgery
NCT00507078
Markers in Exhaled Breath Condensate in Obstructive Sleep Apnoea (OSA) Patients
NCT00287638
Role of Biomarkers to Screen for Obstructive Sleep Apnea
NCT04093102
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP
Patients with moderate/severe OSAS will be treated with CPAP
No interventions assigned to this group
Control
Patients with snoring will not be subject to treatment with CPAP
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 25-60 years
* Mild/Moderate/Severe OSAS
Exclusion Criteria
* Other sleep disorders
* Previous CPAP therapy
* Type 1 diabetes mellitus
* Familiar Dyslipidemia
* Severe organ pathology
* Acute disease
25 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro de Estudos de Doenças Crónicas
OTHER
NOVA Medical School
OTHER
Centro Hospitalar Lisboa Norte
OTHER
Instituto Nacional de Saúde Dr. Ricardo Jorge
UNKNOWN
Biotempo
UNKNOWN
Fundação para a Ciência e a Tecnologia
OTHER
Universidade Nova de Lisboa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amélia Feliciano, MD
Role: PRINCIPAL_INVESTIGATOR
Centro Hospitalar Lisboa Norte
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Hospitalar Lisboa Norte
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FCM-
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.